Thermo Fisher Scientific Introduces Novel Pre-Transplant Risk Assessment Assay

Thermo Fisher Scientific, the world leader in serving science, has introduced a new pre-transplant risk assessment assay via its CLIA laboratory in Fishe...

July 30, 2024 | Tuesday | News
European Commission Approves AbbVie’s SKYRIZI® for Treatment of Moderately to Severely Active Ulcerative Colitis

AbbVie announced that the European Commission has approved SKYRIZI® (risankizumab) for the treatment of adult patients with moderately to severely ac...

July 29, 2024 | Monday | News
Inventiva Secures Japanese Patent for Lanifibranor in Cirrhosis Treatment

Inventiva , a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with met...

July 26, 2024 | Friday | News
Kronos Bio Initiates Dosing of First Patient in Expansion Cohort with KB-0742 for High-Grade Serous Ovarian Cancer

Kronos Bio, a company dedicated to developing small molecule therapeutics that address cancers and other diseases driven by deregulated transcription, to...

July 24, 2024 | Wednesday | News
Bio-Rad Laboratories Announces Strategic Advances in Life Science and Clinical Diagnostics

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products,  provides an overview of advances supporting th...

July 24, 2024 | Wednesday | News
Lario Therapeutics Receives $6 Million Grant from MJFF for Innovative Parkinson’s Disease Research

Award supports preclinical research of Lario’s CaV2.3 calcium channel inhibitors as a novel disease-modifying approach for treatment of Par...

July 23, 2024 | Tuesday | News
Johnson & Johnson Seeks FDA Approval for SPRAVATO® Nasal Spray as Monotherapy for Treatment-Resistant Depression

Johnson & Johnson  announced  the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) s...

July 23, 2024 | Tuesday | News
Valneva Secures $41.3 Million from CEPI and EU to Expand Access to Chikungunya Vaccine IXCHIQ®

Valneva to receive up to $41.3 million from CEPI and the European Union to expand access to chikungunya vaccine, IXCHIQ® Funding will support clin...

July 22, 2024 | Monday | News
GC Cell and Lukas Biomedical Forge Strategic International Partnership

 GC Cell Corporation (hereinafter referred to as "GC Cell"; 144510:KOSDAQ) and Lukas Biomedical Co., Ltd. (hereinafter referred to as "Lukas," TWSE ...

July 22, 2024 | Monday | News
Shanghai Junshi Biosciences' sNDA for Toripalimab and Bevacizumab Combo for Advanced Liver Cancer Accepted by NMPA

  Shanghai Junshi Biosciences Co., a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercializati...

July 19, 2024 | Friday | News
AstraZeneca Completes Acquisition of Amolyt Pharma for $1.05 Billion

  Amolyt Pharma, a global, clinical-stage biopharmaceutical company specializing in developing therapeutic peptides for rare endocrine and related di...

July 15, 2024 | Monday | News
AusperBio Therapeutics Secures $37 Million Series A Financing

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to ...

July 15, 2024 | Monday | News
Rznomics Inc. Receives Approval for Phase 1/2a Clinical Trial of RZ-004 in Australia

Rznomics Inc., a South Korea based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, announced that it has receive...

July 15, 2024 | Monday | News
Thermo Fisher Scientific to Advance Myeloid Cancer Research with Next-Generation Sequencing Technology

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is proud to announce its partnership with the National Cancer Institute (...

July 12, 2024 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close